Compare ALX & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALX | ABCL |
|---|---|---|
| Founded | 1928 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1994 | 2020 |
| Metric | ALX | ABCL |
|---|---|---|
| Price | $230.57 | $3.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | 41.7K | ★ 2.2M |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | ★ 7.91% | N/A |
| EPS Growth | N/A | ★ 10.91 |
| EPS | ★ 5.50 | N/A |
| Revenue | ★ $213,183,000.00 | $75,128,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25.44 |
| P/E Ratio | $41.38 | ★ N/A |
| Revenue Growth | N/A | ★ 160.56 |
| 52 Week Low | $189.05 | $1.89 |
| 52 Week High | $260.84 | $6.52 |
| Indicator | ALX | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 39.88 | 52.21 |
| Support Level | $229.26 | $3.37 |
| Resistance Level | $235.65 | $3.57 |
| Average True Range (ATR) | 6.89 | 0.15 |
| MACD | -1.52 | 0.01 |
| Stochastic Oscillator | 22.11 | 59.90 |
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing, and redeveloping its properties. It has five properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City, which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.